Disease course in melanoma often cannot be accurately predicted by means of the prognostic factors usually considered in patients with melanoma; therefore, new factors are clearly needed. Increasingly robust scientific evidence shows that tumor lymph vessels play a key role in melanoma that metastasizes by lymphatic and hematogenous pathways. We review current knowledge and examine the implications of lymphangiogenesis in the diagnosis, treatment, and prognosis of patients with melanoma.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1016/j.ad.2014.02.013 | DOI Listing |
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!